HIGHLIGHTS
- who: Zenan Chen et al. from the International Institute of Cryosurgery, Austria University of Michigan, United States have published the paper: Progress in the cryoablation and cryoimmunotherapy for tumor, in the Journal: (JOURNAL)
- what: As mentioned in the beginning of the article, cryoablation is considered to be the main consideration for combination immunotherapy because imaging monitoring can better control the ablation area and guide the ablation needle, reduce complications, surgical costs, and patient recovery time .Although all ablation techniques result in release of tumor antigens in situ, cryoablation is Frontiers in Immunology frontiersin.org 10 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.